Sana Biotechnology (SANA) Stock Price, Quote, News & History

Comments

Sana Biotechnology Inc (SANA) Stock Price, Quote, News & History

SANANASDAQ

Trade with Public

$3.33

0.185.71%

At close: Mar 9, 5:00 PM EST

$3.34

0.010.30%

After Hours: 7:31 PM EST

Earnings: Q4 2025 Earnings were released on Tue Mar 3rd, after the market close

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$3.08

Close

$3.33

Volume / Avg.

0 / 2.90M

Day Range

$3.04 - $3.35

52 Wk Range

1.26 - 6.55

Market Cap

$848.00M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

40

Short Interest

43.73%

Days to Cover

17.28

Recent Sana Biotechnology Inc News

Quantum Computer That Could 'Hack Everyone's Crypto': Why Eric Jackson Is Betting On BTQ Technologies As His Next 100-Bagger

Eric Jackson names BTQ his next 100-bagger, betting it can stop quantum computers from "hacking everyone's crypto."

Rishabh Mishra

Sana Biotech Stock — The Next '100-Bagger'?

Sana Biotech stock soars after outspoken stock promoter Eric Jackson names it as his latest potential "100-bagger."

Erica Kollmann

Morgan Stanley, T1 Energy, Bunge Global, Bank of America And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-143.83M

Investing Cash Flow (TTM)

-40.24M

Financing Cash Flow (TTM)

128.73M

Free Cash Flow (TTM)

-144.77M

Capital Expenditure (TTM)

-938.00K

Net Change in Cash (TTM)

-55.33M

Analyst Trends and Forecast

1

Sep 25

0

Oct 25

2

Nov 25

1

Jan

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$830.48M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

5.53

Earnings Yield % (TTM)

-28.79%

Earnings Yield % (FWD)

-15.89%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.60

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

$126.40M

LT Debt Repayment (TTM)

-$347.00K

Total Cash

$71.87M

Debt to Equity

0.49

Issuance of Debt (TTM)

$126.06M

Repayment of Debt (TTM)

-$347.00K

Key Statistics

Open

$3.08

Close

$3.33

Volume / Avg.

0 / 2.90M

Day Range

$3.04 - $3.35

52 Wk Range

1.26 - 6.55

Market Cap

$848.00M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

40

Short Interest

43.73%

Days to Cover

17.28

About

Sector

Health Care

Industry

Biotechnology

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatmen...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Sana Biotechnology (SANA) stock?

A

You can purchase shares of Sana Biotechnology (NASDAQ:SANA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Sana Biotechnology (SANA) competitors?

A

Other companies in Sana Biotechnology’s space includes: Bright Minds Biosciences Inc (NASDAQ:DRUG), Tectonic Therapeutic Inc (NASDAQ:TECX), ARS Pharmaceuticals Inc (NASDAQ:SPRY), KalVista Pharmaceuticals Inc (NASDAQ:KALV) and CytomX Therapeutics Inc (NASDAQ:CTMX).

Q

What is the forecast, or price target, for Sana Biotechnology (SANA) stock?

A

Sana Biotechnology has a consensus price target of $8.00.

Q

What is the current price for Sana Biotechnology (SANA)?

A

The stock price for Sana Biotechnology (NASDAQ: SANA) is $3.34 last updated March 9, 2026 at 7:31 PM EDT.

Q

Does Sana Biotechnology (SANA) pay a dividend?

A

There are no upcoming dividends for Sana Biotechnology.

Q

When is Sana Biotechnology (NASDAQ:SANA) reporting earnings?

A

Sana Biotechnology does not have any upcoming earnings scheduled.

Q

Is Sana Biotechnology (SANA) going to split?

A

There is no upcoming split for Sana Biotechnology.

Q

What sector and industry does Sana Biotechnology (SANA) operate in?

A

Sana Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Bright Minds Biosciences Inc

NASDAQ:DRUG

$80.46

%

Tectonic Therapeutic Inc

NASDAQ:TECX

$34.00

%

ARS Pharmaceuticals Inc

NASDAQ:SPRY

$9.15

1.10%

KalVista Pharmaceuticals Inc

NASDAQ:KALV

$17.31

0.08%

CytomX Therapeutics Inc

NASDAQ:CTMX

$5.00

-0.60%

Gyre Therapeutics Inc

Key Statistics

Open

$3.08

Close

$3.33

Volume / Avg.

0 / 2.90M

Day Range

$3.04 - $3.35

52 Wk Range

1.26 - 6.55

Market Cap

$848.00M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

40

Short Interest

43.73%

Days to Cover

17.28

Recent Sana Biotechnology Inc News

Quantum Computer That Could 'Hack Everyone's Crypto': Why Eric Jackson Is Betting On BTQ Technologies As His Next 100-Bagger

Eric Jackson names BTQ his next 100-bagger, betting it can stop quantum computers from "hacking everyone's crypto."

Rishabh Mishra

Sana Biotech Stock — The Next '100-Bagger'?

Sana Biotech stock soars after outspoken stock promoter Eric Jackson names it as his latest potential "100-bagger."

Erica Kollmann

Morgan Stanley, T1 Energy, Bunge Global, Bank of America And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-143.83M

Investing Cash Flow (TTM)

-40.24M

Financing Cash Flow (TTM)

128.73M

Free Cash Flow (TTM)

-144.77M

Capital Expenditure (TTM)

-938.00K

Net Change in Cash (TTM)

-55.33M

Analyst Trends and Forecast

1

Sep 25

0

Oct 25

2

Nov 25

1

Jan

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$830.48M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

5.53

Earnings Yield % (TTM)

-28.79%

Earnings Yield % (FWD)

-15.89%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.60

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

$126.40M

LT Debt Repayment (TTM)

-$347.00K

Total Cash

$71.87M

Debt to Equity

0.49

Issuance of Debt (TTM)

$126.06M

Repayment of Debt (TTM)

-$347.00K

Key Statistics

Open

$3.08

Close

$3.33

Volume / Avg.

0 / 2.90M

Day Range

$3.04 - $3.35

52 Wk Range

1.26 - 6.55

Market Cap

$848.00M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

40

Short Interest

43.73%

Days to Cover

17.28

About

Sector

Health Care

Industry

Biotechnology

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatmen...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry